Offer - Urjas Oil for just ₹ 1 X
Olmezest Beta 40 Mg/50 Mg Tablet is a prescription medicine that is available as a Tablet. Other than this, Olmezest Beta 40 Mg/50 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Olmezest Beta 40 Mg/50 Mg Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Olmezest Beta 40 Mg/50 Mg Tablet are Upper respiratory tract infection, Slow heart rate (pulse). While these are the most often observed Olmezest Beta 40 Mg/50 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Olmezest Beta 40 Mg/50 Mg Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Olmezest Beta 40 Mg/50 Mg Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. Further, the section on Olmezest Beta 40 Mg/50 Mg Tablet related warnings talks about Olmezest Beta 40 Mg/50 Mg Tablet's effects on the liver, heart and kidney.
Olmezest Beta 40 Mg/50 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) are examples of such conditions. Other conditions have been mentioned below in the Olmezest Beta 40 Mg/50 Mg Tablet contraindications section.
Drug reaction of Olmezest Beta 40 Mg/50 Mg Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Olmezest Beta 40 Mg/50 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Olmezest Beta 40 Mg/50 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmezest Beta 40 Mg/50 Mg Tablet safe for pregnant women?
Olmezest Beta shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmezest Beta 40 Mg/50 Mg Tablet safe during breastfeeding?
Olmezest Beta has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmezest Beta 40 Mg/50 Mg Tablet on the Kidneys?
Olmezest Beta is completely safe for kidneys.
What is the effect of Olmezest Beta 40 Mg/50 Mg Tablet on the Liver?
Side effects of Olmezest Beta rarely affect the liver.
What is the effect of Olmezest Beta 40 Mg/50 Mg Tablet on the Heart?
Olmezest Beta may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Olmezest Beta 40 Mg/50 Mg Tablet unless your doctor advises you to do so -
Is this Olmezest Beta 40 Mg/50 Mg Tablet habit forming or addictive?
No, there is no any evidence that Olmezest Beta 40 Mg/50 Mg Tablet is addictive.
Interaction between Food and Olmezest Beta 40 Mg/50 Mg Tablet
Taking Olmezest Beta 40 Mg/50 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmezest Beta 40 Mg/50 Mg Tablet
Consumption of alcohol and Olmezest Beta 40 Mg/50 Mg Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850